Abstract:Parkinson's disease (PD) is a movement disorder with widespread neurodegeneration in the brain. Significant oxidative, reductive, metabolic, and proteotoxic alterations have been observed in PD postmortem brains. The alterations of mitochondrial function resulting in decreased bioenergetic health is important and needs to be further examined to help develop biomarkers for PD severity and prognosis. It is now becoming clear that multiple hits on metabolic and signaling pathways are likely to exacerbate PD pathogenesis. Indeed, data obtained from genetic and genome association studies have implicated interactive contributions of genes controlling protein quality control and metabolism. For example, loss of key proteins that are responsible for clearance of dysfunctional mitochondria through a process called mitophagy has been found to cause PD, and a significant proportion of genes associated with PD encode proteins involved in the autophagy-lysosomal pathway. In this review, we highlight the evidence for the targeting of mitochondria by proteotoxic, redox and metabolic stress, and the role autophagic surveillance in maintenance of mitochondrial quality. Furthermore, we summarize the role of α-synuclein, leucine-rich repeat kinase 2, and tau in modulating mitochondrial function and autophagy. Among the stressors that can overwhelm the mitochondrial quality control mechanisms, we will discuss 4-hydroxynonenal and nitric oxide. The impact of autophagy is context depend and as such can have both beneficial and detrimental effects. Furthermore, we highlight the potential of targeting mitochondria and autophagic function as an integrated therapeutic strategy and the emerging contribution of the microbiome to PD susceptibility.

Mitochondria-mediated damage to dopaminergic neurons in Parkinson's disease (Review)

Progress relating to mitochondria dysfunction and Parkinson disease

Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy

Mitochondrial Dysfunction in Parkinson's Disease: Pathogenesis and Neuroprotection

Dysregulation of autophagy and mitochondrial function in Parkinson's disease.

Significance of Mitochondrial Dysfunction in the Pathogenesis of Parkinson's Disease

Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease

Role of mitochondrial damage and repair in Parkinson′s disease

Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson’s Disease

Correlation Between Mitochondrial Dysfunction and the Pathogenesis of Parkinson's Disease

Ameliorating Mitochondrial Dysfunction for the Therapy of Parkinson's Disease

Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease

Mitophagy, a Form of Selective Autophagy, Plays an Essential Role in Mitochondrial Dynamics of Parkinson’s Disease

Mitophagy in Parkinson’s Disease: From Pathogenesis to Treatment

Mitochondrial Dysfunction in Parkinson’s Disease: New Mechanistic Insights and Therapeutic Perspectives

Intracellular and Intercellular Mitochondrial Dynamics in Parkinson's Disease

The epigenetic mechanisms involved in mitochondrial dysfunction: Implication for Parkinson's disease

Potential Implications of Mitochondrial Unfolded Protein Response in the Pathogenesis and Therapy of Dopaminergic Neuron Degeneration in Parkinson ’ s Disease

Mitochondrial Contribution to Parkinson's Disease Pathogenesis

Mitochondria as an easy target to oxidative stress events in Parkinson's disease.

Chaperone-Mediated Autophagy and Mitochondrial Homeostasis in Parkinson’s Disease